Transplantation of a human ovarian cystadenocarcinoma into severe combined immunodeficient (SCID) mice - Formation of metastases without significant alteration of the tumour cell phenotype

International Journal of Experimental Pathology

Volumn 77, Issue 5, 1996, Pages 219-227

  Schumacher, U ^a   Adam, E ^a   Horny, H P ^b   Dietl, J ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cell adhesion molecules; Cell proliferation marker; Electron microscopy; Helix pomatia agglutinin; Metastasis; Orthotopic transplantation; Ovarian cancer; Severe combined immunodeficient mice; Tumour marker

Indexed keywords

CELL ADHESION MOLECULE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; HELIX POMATIA; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; NONHUMAN; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; ULTRASTRUCTURE;

EID: 0029862581     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.1996.9860324.x     Document Type: Article

References (23)

1. ASTOUL P., COLT, H.G., WANG, X. & HOFFMAN R.M. (1993) Metastatic human pleural ovarian cancer model constructed by orthotopic implantation of fresh histologically-intact patient carcinoma in nude mice. Anticancer Res. 13, 1999-2002.
2. BIRCHMEIER W. (1995) E-cadherin as a tumor (invasion) suppressor gene. BioEssays 17, 97-99.
3. BIRCHMEIER W. & BEHRENS, J. (1994) Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta 1198, 11-26.
4. BUMPERS H L, ALOSCO T.R., WANG H.-Q., PETRELLI N.J., HOOVER E.L. & BANKERT, R B. (1994) Human villous adenomas engrafted into seid mice survive for prolonged periods without malignant transformation. J. Clin. Invest. 94, 2153-2157.
5. CHEN F.A., ALOSCO T, CROY B.A., NARUMI K., PERCY D.H. & BANKERT, R.B. (1994) Clones of tumor cells derived from a single primary human lung tumor reveal different patterns of beta 1 integrin expression. Cell Adhes. Commun. 2, 345-357.
6. DOLD U & SACK H. (1980) Praktische Tumortherapie. Second edition, Stuttgart, Thieme, p 339.
7. FENOGLIO C.M. (1980) Overview article: Ultrastructural features of the common epithelial tumours of the ovary. Ultrastruct. Pathol. 1, 419-444.
8. FODSTAD O & KJONNIKSEN, I (1994) Microenvironment revisited: time for reappraisal of some prevailing concepts of cancer metastasis. J. Cell. Biochem. 56, 23-28.
9. FREI E. (1982) The national chemotherapy programme. Science 217, 600-606.
10. FU X. & HOFFMAN R.M. (1993) Human ovarian carcinoma meta-static models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens. Anticancer Res., 283-286.
11. GAROFALO A, CHIRIVI R G, SCANZIANI E, MAYOR J.G., VECCHI A & GIAVAZZI R. (1993) Comparative study on the metastatic behaviour of human tumours in nude, beige/nude/xid and severe combined immunodeficient mice. Invasion Metastasis 13, 82-91.
12. HASHIMOTO M., NIWA O, NITTA Y., TAKEICHI M. & YOKORO K (1989) Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn. J. Cancer Res. 80, 459-463.
13. HILLS C.A., KELLAND L.R., ABEL G., SIRACKY J., WILSON A.P. & HARRAP K.R. (1989) Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes. Br. J. Cancer 59, 527-534.
14. HSU M., RAINE L. & FANGER H. (1981) Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem Cytochem. 29, 577-580.
15. MALIK S.T., MARTIN D., HART I. & BALKWILL F. (1991) Therapy of human ovarian cancer xenografts with intraperitoneal liposome encapsulated muramyl-tripeptide phosphoethanolamine (MTP-PE) and recombinant GM-CSF. Br.J. Cancer 63, 399-403.
16. SCHUMACHER U., ADAM E., BROOKS S.A. & LEATHEM A.J. (1995a) Lectin-binding properties of human breast cancer cell lines and human milk with particular reference to Helix pomatia agglutinin. J. Histochem. Cytochem. 43, 275-281.
17. SCHUMACHER U., ADAM E, FLAVELL D.A., BOEHM D., BROOKS S.A. & LEATHEM A.J. (1994) Glycosylation pattern of the human colon cancer cell line HT29 detected by Helix pomatia agglutinin and other lectins in culture in primary tumours and in metastases in SCID-mice. Clin. Exp. Metast. 12, 398-404.
18. SCHUMACHER U., STAMOULI A., ADAM E., PEDDIE M. & PFÜLLER U. (1995b) Biochemical, histochemical and cell biological investigations on the actions of mistletoe lectins I, II and III with human breast cancer cell lines. Glycoconjugate J. 12, 250-257.
19. SPICER S.S. & SCHULTE B.A. (1992) Diversity of cell glycoconjugates shown histochemically: A perspective. J. Histochem. Cytochem. 40, 1-38.
20. VENDITTI J.M. (1983) The National Cancer Institute antitumour drug discovery programme. Cancer Treat. Rep. 67, 767-772.
21. WALTER I. (1995) Culture of bovine oviduct epithelial cells (BOEC). Anat. Rec. 243, 347-356.
22. WILLIAMS S.S., ALOSCO T.R., CROY B.A. & BANKERT R. (1993) The study of human neoplastic disease in severe combined immunodeficient mice. Lab. Animal. Sci. 43, 139-146.
23. WILSON A.P. (1984) Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary. J. Natl. Canc. Inst. 72, 513-521.